Sentinel Node Biopsy for Melanoma: An Update After Two Decades of Experience

Seminars in Cutaneous Medicine and Surgery

Volumn 29, Issue 4, 2010, Pages 238-248

  Ross, Merrick I ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN;

ALLERGIC REACTION; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL (TOPIC); ELECTIVE SURGERY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOLOGY; IN-TRANSIT METASTASIS; LYMPH NODE DISSECTION; LYMPHEDEMA; MELANOMA; PATIENT SELECTION; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENTINEL LYMPH NODE BIOPSY; SEROMA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR VOLUME; WOUND COMPLICATION;

HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM STAGING; PATIENT SELECTION; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 79251509556     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sder.2010.11.002     Document Type: Review

References (84)

1. Balch C.M., Gershenwald J.E., Soong S.J., et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009, 27:6199-6206.
2. Morton D.L., Wen D.R., Wong J.H., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992, 127:392-399.
3. Ross M.I. Surgical management of stage I and II melanoma patients: Approach to the regional lymph node basin. Semin Surg Oncol 1996, 12:394-401.
4. Balch C.M., Soong S.J., Gershenwald J.E., et al. Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001, 19:3622-3634.
5. Balch C.M., Gershenwald J.E., Soong S.J., et al. Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: Comparison of nodal micrometastases versus macrometastases. J Clin Oncol 2010, 28:2452-2459.
6. Lee R.J., Gibbs J.F., Proulx G.M., et al. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 2000, 46:467-474.
7. O'Brien C.J., Coates A.S., Petersen-Schaefer K., et al. Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg 1991, 162:310-314.
8. Calabro A., Singletary S.E., Balch C.M. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg 1989, 124:1051-1055.
9. Ballo M.T., Strom E.A., Zagars G.K., et al. Adjuvant irradiation for axillary metastases from malignant melanoma. Int J Radiat Oncol Biol Phys 2002, 52:964-972.
10. Slingluff C.L., Stidham K.R., Ricci W.M., et al. Surgical management of regional lymph nodes in patients with melanoma: Experience with 4682 patients (see comments). Ann Surg 1994, 219:120-130.
11. Gershenwald J.E., Berman R.S., Porter G., et al. Regional Nodal Basin control is not Compromised by Previous Sentinel lymph node Biopsy in patients with Melanoma. Ann Surg Oncol 2000, 7:226-231.
12. Balch C.M., Soong S., Ross M.I., et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). InterGroup Melanoma Surgical Trial. Ann Surg Oncol 2000, 7:87-97.
13. Cascinelli N., Morabito A., Santinami M., et al. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet 1998, 351:793-796.
14. Sim F.H., Taylor W.F., Pritchard D.J., et al. Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc 1986, 61:697-705.
15. Veronesi U., Adamus J., Bandiera D.C., et al. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med 1977, 297:627-630.
16. Ross M.I., Reintgen D., Balch C.M. Selective lymphadenectomy: Emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. Semin Surg Oncol 1993, 9:219-223.
17. Reintgen D., Cruse C.W., Wells K., et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994, 220:759-767.
18. Thompson J.F., McCarthy W.H., Bosch C.M., et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995, 5:255-260.
19. Gershenwald J.E., Tseng C.H., Thompson W., et al. Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloid. Surgery 1998, 124:203-210.
20. Gershenwald J.E., Colome M.I., Lee J.E., et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998, 16:2253-2260.
21. Cook M.G., Green M.A., Anderson B., et al. The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol 2003, 200:314-319.
22. Reintgen D., Balch C.M., Kirkwood J., et al. Recent advances in the care of the patient with malignant melanoma. Ann Surg 1997, 225:1-14.
23. Shivers S.C., Wang X., Li W., et al. Molecular staging of malignant melanoma: Correlation with clinical outcome. JAMA 1998, 280:1410-1415.
24. Wang X., Heller R., VanVoorhis N., et al. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 1994, 220:768-774.
25. Kammula U.S., Ghossein R., Bhattacharya S., et al. Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction-Staged sentinel lymph nodes from melanoma patients. J Clin Oncol 2004, 22:3989-3996.
26. Scoggins C.R., Ross M.I., Reintgen D.S., et al. Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma. J Clin Oncol 2006, 24:2849-2857.
27. Prieto V.G., Clark S.H. Processing of sentinel lymph nodes for detection of metastatic melanoma. Ann Diagn Pathol 2002, 6:257-264.
28. Scolyer R.A., Murali R., McCarthy S.W., et al. Pathologic examination of sentinel lymph nodes from melanoma patients. Semin Diagn Pathol 2008, 25:100-111.
29. Scolyer R.A., Thompson J.F., McCarthy S.W., et al. Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patients. J Am Coll Surg 2005, 201:821-823. author reply: 823-824.
30. Stojadinovic A., Allen P.J., Clary B.M., et al. Value of frozen-section analysis of sentinel lymph nodes for primary cutaneous malignant melanoma. Ann Surg 2002, 235:92-98.
31. Soo V., Shen P., Pichardo R., et al. Intraoperative evaluation of sentinel lymph nodes for metastatic melanoma by imprint cytology. Ann Surg Oncol 2007, 14:1612-1617.
32. Chakera A.H., Hesse B., Burak Z., et al. EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. Eur J Nucl Med Mol Imaging 2009, 36:1713-1733.
33. Berger D.H., Feig B.W., Podoloff D., et al. Lymphoscintigraphy as a predictor of lymphatic drainage from cutaneous melanoma. Ann Surg Oncol 1997, 4:247-251.
34. Uren R.F., Howman-Giles R., Thompson J.F., et al. Lymphoscintigraphy to identify sentinel lymph nodes in patients with melanoma. Melanoma Res 1994, 4:395-399.
35. Clary B.M., Brady M.S., Lewis J.J., et al. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: Review of a large single-institutional experience with an emphasis on recurrence. Ann Surg 2001, 233:250-258.
36. Albertini J.J., Cruse C.W., Rapaport D., et al. Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996, 223:217-224.
37. Kapteijn B.A., Nieweg O.E., Liem I., et al. Localizing the sentinel node in cutaneous melanoma: Gamma probe detection versus blue dye. Ann Surg Oncol 1997, 4:156-160.
38. Krag D.N., Meijer S.J., Weaver D.L., et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995, 130:654-658. discussion: 659-660.
39. Kretschmer L., Thoms K.M., Peeters S., et al. Postoperative morbidity of lymph node excision for cutaneous melanoma-sentinel lymphonodectomy versus complete regional lymph node dissection. Melanoma Res 2008, 18:16-21.
40. Sumner W.E., Ross M.I., Mansfield P.F., et al. Implications of lymphatic drainage to unusual sentinel lymph node sites in patients with primary cutaneous melanoma. Cancer 2002, 95:354-360.
41. Thompson J.F., Uren R.F., Shaw H.M., et al. Location of sentinel lymph nodes in patients with cutaneous melanoma: New insights into lymphatic anatomy. J Am Coll Surg 1999, 189:195-204.
42. Uren R.F., Howman-Giles R., Thompson J.F., et al. Interval nodes: the forgotten sentinel nodes in patients with melanoma. Arch Surg 2000, 135:1168-1172.
43. Uren R.F., Thompson J.F., Howman-Giles R. Sentinel nodes. Interval nodes, lymphatic lakes, and accurate sentinel node identification. Clin Nucl Med 2000, 25:234-236.
44. Uren R.F., Thompson J.F., Howman-Giles R., et al. Melanoma metastases in triangular intermuscular space lymph nodes. Ann Surg Oncol 1999, 6:811.
45. Uren R.F. SPECT/CT lymphoscintigraphy to locate the sentinel lymph node in patients with melanoma. Ann Surg Oncol 2009, 16:1459-1460.
46. Cascinelli N., Belli F., Santinami M., et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol 2000, 7:469-474.
47. McMasters K.M., Wong S.L., Edwards M.J., et al. Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma. Surgery 2001, 130:151-156.
48. Rousseau D.L., Ross M.I., Johnson M.M., et al. Revised American joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients. Ann Surg Oncol 2003, 10:569-574.
49. Thompson J.F. The Sydney Melanoma Unit experience of sentinel lymphadenectomy for melanoma. Ann Surg Oncol 2001, 8(9 suppl):44S-47S.
50. Petersson F., Diwan A.H., Ivan D., et al. Immunohistochemical detection of lymphovascular invasion with D2-40 in melanoma correlates with sentinel lymph node status, metastasis and survival. J Cutan Pathol 2009, 36:1157-1163.
51. Doeden K., Ma Z., Narasimhan B., et al. Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis. J Cutan Pathol 2009, 36:772-780.
52. Sondak V.K., Taylor J.M., Sabel M.S., et al. Mitotic rate and younger age are predictors of sentinel lymph node positivity: Lessons learned from the generation of a probabilistic model. Ann Surg Oncol 2004, 11:247-258.
53. Thompson J.F., Shaw H.M. Should tumor mitotic rate and patient age, as well as tumor thickness, be used to select melanoma patients for sentinel node biopsy?. Ann Surg Oncol 2004, v11:233-235.
54. Paek S.C., Griffith K.A., Johnson T.M., et al. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma. Cancer 2007, 109:100-108.
55. Gershenwald J.E., Thompson W., Mansfield P.F., et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999, 17:976-983.
56. Cascinelli N., Bombardieri E., Bufalino R., et al. Sentinel and nonsentinel node status in stage IB and II melanoma patients: Two-step prognostic indicators of survival. J Clin Oncol 2006, 24:4464-4471.
57. Morton D.L., Thompson J.F., Cochran A.J., et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006, 355:1307-1317.
58. Morton D.L., Cochran A.J., Thompson J.F., et al. Sentinel node biopsy for early-stage melanoma: Accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005, 242:302-311. discussion:311-313.
59. Ross M.I., Gershenwald J.E. How should we view the results of the Multicenter Selective Lymphadenectomy Trial-1 (MSLT-1)?. Ann Surg Oncol 2008, 15:670-673.
60. Govindarajan A., Ghazarian D.M., McCready D.R., et al. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse. Ann Surg Oncol 2007, 14:906-912.
61. Vuylsteke R.J., Borgstein P.J., van Leeuwen P.A., et al. Sentinel lymph node tumor load: an independent predictor of additional lymph node involvement and survival in melanoma. Ann Surg Oncol 2005, 12:440-448.
62. Gershenwald J.E., Andtbacka R.H., Prieto V.G., et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol 2008, 26:4296-4303.
63. Wrightson W.R., Wong S.L., Edwards M.J., et al. Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol 2003, 10:676-680.
64. Guggenheim M.M., Hug U., Jung F.J., et al. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma. Ann Surg 2008, 247:687-693.
65. Daley M.D., Norman P.H., Leak J.A., et al. Adverse events associated with the intraoperative injection of isosulfan blue. J Clin Anesth 2004, 16:332-341.
66. Estourgie S.H., Nieweg O.E., Kroon B.B. High incidence of in-transit metastases after sentinel node biopsy in patients with melanoma. Br J Surg 2004, 91:1370-1371.
67. Thomas J.M., Clark M.A. Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma. Eur J Surg Oncol 2004, 30:686-691.
68. van Poll D., Thompson J.F., Colman M.H., et al. A sentinel node biopsy does not increase the incidence of in-transit metastasis in patients with primary cutaneous melanoma. Ann Surg Oncol 2005, 12:597-608.
69. Pawlik T.M., Ross M.I., Thompson J.F., et al. The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes. J Clin Oncol 2005, 23:4588-4590.
70. Pawlik T.M., Ross M.I., Johnson M.M., et al. Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy. Ann Surg Oncol 2005, 12:587-596.
71. Kang J.C., Wanek L.A., Essner R., et al. Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma. J Clin Oncol 2005, 23:4764-4770.
72. Kruper L.L., Spitz F.R., Czerniecki B.J., et al. Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma. Cancer 2006, 107:2436-2445.
73. Agnese D.M., Abdessalam S.F., Burak W.E., et al. Cost-effectiveness of sentinel lymph node biopsy in thin melanomas. Surgery 2003, 134:542-547. discussion: 547-548.
74. Andtbacka R.H., Gershenwald J.E. Role of sentinel lymph node biopsy in patients with thin melanoma. J Natl Compr Cancer Netw 2009, 7:308-317.
75. Kesmodel S.B., Karakousis G.C., Botbyl J.D., et al. Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas. Ann Surg Oncol 2005, 12:449-458.
76. Thompson J.F., Shaw H.M. Sentinel node metastasis from thin melanomas with vertical growth phase. Ann Surg Oncol 2000, 7:251-252.
77. Carlson G.W., Murray D.R., Hestley A., et al. Sentinel lymph node mapping for thick (>or=4-mm) melanoma: Should we be doing it?. Ann Surg Oncol 2003, 10:408-415.
78. Gershenwald J.E., Mansfield P.F., Lee J.E., et al. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma. Ann Surg Oncol 2000, 7:160-165.
79. Jacobs I.A., Chang C.K., Salti G.I. Role of sentinel lymph node biopsy in patients with thick (>4 mm) primary melanoma. Am Surg 2004, 70:59-62.
80. Scoggins C.R., Bowen A.L., Martin R.C., et al. Prognostic information from sentinel lymph node biopsy in patients with thick melanoma. Arch Surg 2010, 145:622-627.
81. Gajdos C., Griffith K.A., Wong S.L., et al. Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma?. Cancer 2009, 115:5752-5760.
82. Lohmann C.M., Coit D.G., Brady M.S., et al. Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors. Am J Surg Pathol 2002, 26:47-55.
83. Gannon C.J., Rousseau D.L., Ross M.I., et al. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma. Cancer 2006, 107:2647-2652.
84. Balch C.M., Morton D.L., Gershenwald J.E., et al. Sentinel node biopsy and standard of care for melanoma. J Am Acad Dermatol 2009, 60:872-875.